The shares of Sampre Nutritions Limited opened at Rs 109 and rose to Rs 112 to be locked in an upper circuit of 5 per cent on the last trading day of the week. In the past five days, the stock has risen by approximately 17 per cent.
The shares rallied on Friday after Mauritius-based foreign investment agency Eriska Investment Fund bought 50,000 shares of the company. The shares were bought at a price of Rs 101 a piece. This makes a total investment value of Rs 50.50 lakh.
A year ago the company’s shares were trading at Rs 16.95 a piece on BSE. From there it has climbed up to the current levels, logging a multibagger return of 564%.
If an investor has invested Rs 1 lakh in the company a year ago their shares would be worth Rs 6.64 lakhs today.
In the span of a month, the stock has gained more than 42 per cent and in the time frame of two months, the stock has logged a return of 189 per cent. So far this year in 2022 the stock has delivered a multibagger return of 240 per cent YTD.
Sampre Nutritions Ltd, a Gurbani Group company, is a one-stop shop for the development of confectionery chocolates, hard-boiled candies, etc. Some of the notable group clients of the company include P&G, Boots, Cipla, Ranbaxy, Mondelez Foods Pvt Ltd (Formerly Cadbury India Limited), Future Group, Patanjali, Dabur, etc.
In Q1FY23, the company reported total revenue of Rs 8 crores up from Rs 2 crores which they reported in the same period a year earlier. Their net profits stood at Rs 22 lakhs in the quarter under review as compared to a loss of Rs 1.2 crores which they incurred in Q1FY22.
The BSE-listed microcap company has a market capitalization of Rs 54 crores as on September 16th 2022. The promoters of the company hold a stake of 52.78 per cent with zero shares pledged.
Written by Anoushka Roy
Disclaimer
The content in this news article is not investment advice. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
